Paclitaxel-Primed Mesenchymal Stem Cells
Corresponding Organization :
Other organizations : University of Milan, Fondazione IRCCS Istituto Neurologico Carlo Besta, Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna "Bruno Ubertini", Fondazione IRCCS Istituto Nazionale dei Tumori, University of Brescia, Università Cattolica del Sacro Cuore, Institute of Neurobiology and Molecular Medicine
Protocol cited in 8 other protocols
Variable analysis
- PTX (2.000 ng/ml)
- Anti-tumor proliferation activity
- Passive membrane drug adsorption and release by fixed cells
- Internalization of PTX into MSCs
- Effect of 24 h drug treatment on the cell cycle of MSCs
- Cell conditioned medium (CM) from untreated MSCs
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!